Thabiso Mutirwara mutirwarat@dailynews.co.zw A CLINICAL trial for a ground-breaking HIV vaccine has been launched in the country. The novel vaccine candidate will evaluate immune responses to highly networked HIV T-cell epitopes. The trial is a result of close collaboration among the Africa Clinical Research Network, the Mutala Trust, ReiThera Srl (ReiThera), the Ragon Institute of…
A futuristic HIV vaccine trialled

The vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1), was first administered on July 28, 2025.